Shri Vasuprada Plantations Intrinsic Value
Shri Vasuprada Plantations (VASUPRADA) median intrinsic value is ₹135.00 from 3 valuation models (range ₹70–₹253), vs current price ₹101.00 — +33.7% upside (Trading Below Calculated Value), margin of safety 25.2%. Read VASUPRADA ex-dividend dates for the complete payout history and dividend yield track record.
VASUPRADA Valuation Methods Summary — DCF, Graham Number & P/E
Shri Vasuprada Plantations intrinsic value across 3 models vs current price ₹101.00 — upside/downside and value range per method. Analyse VASUPRADA institutional holdings to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹252.50 | ₹227.25 - ₹277.75 | +150.0% | Book Value/Share: ₹150.00, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹135.00 | ₹121.50 - ₹148.50 | +33.7% | Revenue/Share: ₹90.00, P/S: 1.5x |
| Simple DCF (5Y) | dcf | ₹69.63 | ₹55.70 - ₹83.56 | -31.1% | CF Growth: 5.0%, Discount: 15% |
VASUPRADA Intrinsic Value vs Market Price — All Valuation Models
Shri Vasuprada Plantations fair value range ₹70–₹253 vs current market price ₹101.00 across 3 valuation models. For current market price and key ratios, visit Shri Vasuprada Plantations share price chart.
VASUPRADA Intrinsic Value Analysis — Undervalued or Overvalued?
Shri Vasuprada Plantations median intrinsic value ₹135.00, current price ₹101.00 — Trading Below Calculated Value by 33.7%, margin of safety 25.2%.
What is the intrinsic value of VASUPRADA?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Shri Vasuprada Plantations (VASUPRADA) is ₹135.00 (median value). With the current market price of ₹101.00, this represents a +33.7% variance from our estimated fair value.
The valuation range spans from ₹69.63 to ₹252.50, indicating ₹69.63 - ₹252.50.
Is VASUPRADA undervalued or overvalued?
Based on our multi-method analysis, Shri Vasuprada Plantations (VASUPRADA) appears to be trading below calculated value by approximately 33.7%.
VASUPRADA Financial Health — Key Ratios vs Industry Benchmarks
Shri Vasuprada Plantations financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.62 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -23.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.34x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
VASUPRADA Cash Flow Quality — Operating & Free Cash Flow
Shri Vasuprada Plantations operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-9 Cr | ₹-9 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹12 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-3 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |